GATIFLOXACIN FORMULATIONS FOR USING IN PEDIATRICS Russian patent published in 2006 - IPC C07C215/56 C07D401/04 A61K45/08 

Abstract RU 2288218 C2

FIELD: medicine, pediatrics, pharmacy.

SUBSTANCE: invention relates to formulation of antibacterial preparation gatifloxacin prepared as a crystalline combined sediment of gatifloxacin and fatty acid. Method involves dissolving gatifloxacin and fatty acid in the weight ratio from 1:1.8 to 1:2.3 in solvent at heating up to boiling with reflux condenser, boiling this solution with reflux condenser for 2-3 h at stirring, cooling this solution at stirring to temperature about 18°C for 2.5-4 h to precipitate of crystalline combined sediment of gatifloxacin and fatty acid, keeping the prepared suspension of crystalline combined sediment at temperature 15-20°C for 2-4 h and isolating and drying the crystalline combined sediment. Also, invention describes a pharmaceutical composition used in treatment of infections and a method for treatment of infection by using the novel formulation of gatofloxacin. Crystalline combined sediment of gatifloxacin with stearic or palmitic acids taken in the narrow range of weight ratios masks bitter taste of gatifloxacin effectively.

EFFECT: improved preparing method, improved and valuable pharmaceutical properties of drug.

10 cl, 2 ex

Similar patents RU2288218C2

Title Year Author Number
CEFUROXIME AXETYL-CONTAINING PHARMACEUTICAL COMPOSITION WITH MASKED BITTER TASTE 2002
  • Fernandes Matil'De Iban'Es
  • Garris Ehmilio Sans
RU2241460C2
PERORAL PREPARATION AND METHOD OF ITS PRODUCTION 2005
  • Ikuta Khirosi
  • Jadzima Tosio
RU2376013C2
AEROSOL FLUOROCHINOLONES AND THEIR APPLICATIONS 2006
  • Serber Mark U.
  • Bostian Kit A.
  • Lomovskaja Ol'Ga
  • Griffit Dehvid K.
  • Dadli Majkl N.
RU2428986C2
METHOD FOR APPLYING COATING ON ANTIBIOTICS 0
  • Majkl Bernard Dzhejms
  • Leonard Goffri Eliott
SU1837876A3
METHOD FOR PRODUCING RANITIDIN SUITABLE FOR ORAL ADMINISTRATION 1989
  • Stiven Dzhon Duglas[Gb]
  • Fiona Rut Berd[Gb]
RU2033155C1
PHARMACEUTICAL COMPOSITION OF SILDENAFIL CITRATE IN FORM OF SUSPENSION FOR ORAL ADMINISTRATION 2016
  • Gomez-Calvo Antonia
  • Martinez-Alzamora Fernando
  • Rizo-Martinez Miguel
  • Sanz-Menendez Nuria
RU2649834C1
DIRECTLY PRESSED MATRIX FOR REGULATED RELEASE OF SINGLE DAILY CLARITHROMYCIN DOSES 2000
  • Ferchej Temel'Otov Dar'Ja
  • Mokhar Milojka
  • Salobir Mateja
  • Rebich Ljubomira Barbara
  • Opresnik Marko
RU2237480C2
COMPOSITIONS OF ANTIBIOTIC 2004
  • Nandi Indranil
  • Go Min'Ton
  • Gassert Chad Majkl
RU2376980C2
MELT-COVERED PHARMACEUTICAL COMPOSITION WITH FAST RELEASE 2009
  • Peter Kraas
  • Shtefani Bol'D
  • Lars Fazel'
RU2554768C2
COMPOSITION FOR PREPARATION COATING WITH THE REGULATED ACTIVE SUBSTANCE RELEASE 1991
  • Ekhko Akijama[Jp]
  • Naoki Nagakhara[Jp]
  • Minoru Esioka[Jp]
RU2072836C1

RU 2 288 218 C2

Authors

Ragkhavan Krishnasvami S.

Ranadiv Sunanda A.

Bembenek Kennet S.

Benkerru Lutfi

Tron'O Veronik

Korrao Richard G.

Ispozito Luidzhi

Dates

2006-11-27Published

2002-05-10Filed